<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>ParagraphFour.com | gregoryglass | Activity</title>
	<link>https://paragraphfour.com/members/gregoryglass/activity/</link>
	<atom:link href="https://paragraphfour.com/members/gregoryglass/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for gregoryglass.</description>
	<lastBuildDate>Mon, 14 Sep 2026 07:17:48 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">615bdea07061c3c145818d23551fc694</guid>
				<title>gregoryglass updated &#039;Generic Companies Report #1 (A-E) &#039;: The Paragraph Four Report ®
Generic Companies Report #1 [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12348/</link>
				<pubDate>Thu, 03 Sep 2026 20:46:09 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>The Paragraph Four Report ®<br />
Generic Companies Report #1 (A-E)</b></p>
<p><b>List of Companies and Products under active Paragraph IV Certification</b><br />
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an &#8220;Old Case&#8221; (terminated after November 1,&hellip;<span class="activity-read-more" id="activity-read-more-12348"><a href="https://paragraphfour.com/activity/p/12348/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">680c81a5cf0d82e8eceec237e8f7d726</guid>
				<title>gregoryglass updated &#039;Generic Companies Report #2 (F-P) &#039;: The Paragraph Four Report ®
Generic Companies Report #2 [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12346/</link>
				<pubDate>Thu, 03 Sep 2026 20:40:31 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>The Paragraph Four Report ®<br />
Generic Companies Report #2 (F-P)</b></p>
<p><b>List of Companies and Products under active Paragraph IV Certification</b><br />
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an &#8220;Old Case&#8221; (terminated after November 1,&hellip;<span class="activity-read-more" id="activity-read-more-12346"><a href="https://paragraphfour.com/activity/p/12346/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">7d0774ede3cb57a94b7210d3e6a0e317</guid>
				<title>gregoryglass updated &#039;Generic Companies Report #2 (F-P) &#039;: The Paragraph Four Report ®
Generic Companies Report #2 [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12344/</link>
				<pubDate>Wed, 02 Sep 2026 20:32:04 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>The Paragraph Four Report ®<br />
Generic Companies Report #2 (F-P)</b></p>
<p><b>List of Companies and Products under active Paragraph IV Certification</b><br />
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an &#8220;Old Case&#8221; (terminated after November 1,&hellip;<span class="activity-read-more" id="activity-read-more-12344"><a href="https://paragraphfour.com/activity/p/12344/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d34756febe573d3b84fd3010f21921c7</guid>
				<title>gregoryglass updated &#039;Generic Companies Report #1 (A-E) &#039;: The Paragraph Four Report ®
Generic Companies Report #1 [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12343/</link>
				<pubDate>Wed, 02 Sep 2026 20:31:02 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>The Paragraph Four Report ®<br />
Generic Companies Report #1 (A-E)</b></p>
<p><b>List of Companies and Products under active Paragraph IV Certification</b><br />
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an &#8220;Old Case&#8221; (terminated after November 1,&hellip;<span class="activity-read-more" id="activity-read-more-12343"><a href="https://paragraphfour.com/activity/p/12343/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">a7decca2fb1395360835a4f4f8784bc9</guid>
				<title>gregoryglass updated &#039;Branded Companies Report &#039;: The Paragraph Four Report ®
Branded Companies [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12342/</link>
				<pubDate>Wed, 02 Sep 2026 20:30:17 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>The Paragraph Four Report ®<br />
Branded Companies Report</b></p>
<p><b>List of Companies with Products under active Paragraph IV Certification</b><br />
Data includes total number and product and includes products that do not have a lawsuit filed (when verified by other sources). An Asterisk (*) indicates an &#8220;Old Case&#8221; (terminated after November 1, 2003)</p>
<p><b>ABBVIE&hellip;</b><span class="activity-read-more" id="activity-read-more-12342"><a href="https://paragraphfour.com/activity/p/12342/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">79319f50c4ec3c6e11e882f48d50223c</guid>
				<title>gregoryglass updated &#039;Last Month&#8217;s Paragraph IV Highlights &#039;: August 2026</title>
				<link>https://paragraphfour.com/activity/p/12337/</link>
				<pubDate>Mon, 31 Aug 2026 22:09:09 -0400</pubDate>

									<content:encoded><![CDATA[<p>August 2026</p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">e9b041615f1ea45cef2b51806b860256</guid>
				<title>gregoryglass updated &#039;Generic Companies Report #3 (Q-Z) &#039;: The Paragraph Four Report ®
Generic Companies Report #3 [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12334/</link>
				<pubDate>Mon, 31 Aug 2026 20:52:35 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>The Paragraph Four Report ®<br />
Generic Companies Report #3 (Q-Z)</b></p>
<p><b>List of Companies and Products under active Paragraph IV Certification</b><br />
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an &#8220;Old Case&#8221; (terminated after November 1,&hellip;<span class="activity-read-more" id="activity-read-more-12334"><a href="https://paragraphfour.com/activity/p/12334/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">b49ac81d9efb043464653ab6e52fb8cb</guid>
				<title>gregoryglass updated &#039;Branded Companies Report &#039;: The Paragraph Four Report ®
Branded Companies [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12329/</link>
				<pubDate>Mon, 31 Aug 2026 19:43:53 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>The Paragraph Four Report ®<br />
Branded Companies Report</b></p>
<p><b>List of Companies with Products under active Paragraph IV Certification</b><br />
Data includes total number and product and includes products that do not have a lawsuit filed (when verified by other sources). An Asterisk (*) indicates an &#8220;Old Case&#8221; (terminated after November 1, 2003)</p>
<p><b>ABBVIE&hellip;</b><span class="activity-read-more" id="activity-read-more-12329"><a href="https://paragraphfour.com/activity/p/12329/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">483d5139781882bdf821b509a136c95d</guid>
				<title>gregoryglass updated &#039;Generic Companies Report #2 (F-P) &#039;: The Paragraph Four Report ®
Generic Companies Report #2 [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12328/</link>
				<pubDate>Mon, 31 Aug 2026 19:43:10 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>The Paragraph Four Report ®<br />
Generic Companies Report #2 (F-P)</b></p>
<p><b>List of Companies and Products under active Paragraph IV Certification</b><br />
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an &#8220;Old Case&#8221; (terminated after November 1,&hellip;<span class="activity-read-more" id="activity-read-more-12328"><a href="https://paragraphfour.com/activity/p/12328/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">87154fc9c91cf8bb86408842ab80666c</guid>
				<title>gregoryglass updated &#039;Paragraph IV Appellate Judges (Linn &#8211; Newman) &#039;: The Paragraph Four Report®
The Appellate Judges (Linn - [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12326/</link>
				<pubDate>Mon, 31 Aug 2026 18:57:12 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>The Paragraph Four Report®</b><br />
<b>The Appellate Judges (Linn &#8211; Newman)</b></p>
<p>This Section provides data on federal judges who preside in The Federal Circuit Court of Appeals. The Federal Circuit has exclusive appellate jurisdiction over Paragraph IV cases which means that a party that loses in the district court can only appeal the decision to the Federal&hellip;<span class="activity-read-more" id="activity-read-more-12326"><a href="https://paragraphfour.com/activity/p/12326/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">5cb5c7877046b46108f5e16b00ae7e36</guid>
				<title>gregoryglass updated &#039;Paragraph IV Appellate Judges (Schall &#8211; Wallach) &#039;: The Paragraph Four Report®
The Appellate Judges (Schall - [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12325/</link>
				<pubDate>Mon, 31 Aug 2026 18:56:35 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>The Paragraph Four Report®</b><br />
<b>The Appellate Judges (Schall &#8211; Wallach)</b></p>
<p>This Section provides data on federal judges who preside in The Federal Circuit Court of Appeals. The Federal Circuit has exclusive appellate jurisdiction over Paragraph IV cases which means that a party that loses in the district court can only appeal the decision to the&hellip;<span class="activity-read-more" id="activity-read-more-12325"><a href="https://paragraphfour.com/activity/p/12325/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">11e48d1fb1c5598161c8165ada9f54e6</guid>
				<title>gregoryglass updated &#039;Court of Appeals Decisions &#8211; by Case Name &#039;: The Paragraph Four Report®
Court of Appeals Opinions by [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12324/</link>
				<pubDate>Mon, 31 Aug 2026 18:54:44 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>The Paragraph Four Report®</b><br />
<b>Court of Appeals Opinions by Case Name</b></p>
<p>Opinions from the Court of Appeals for the Federal Circuit can be found in several places in ParagraphFour.com. Each Opinion issued for a particular product can be found under the product name, and you can also see how each individual Appellate Judge ruled in their various&hellip;<span class="activity-read-more" id="activity-read-more-12324"><a href="https://paragraphfour.com/activity/p/12324/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d5a1d706a8a34e4b712cfc54e11e543a</guid>
				<title>gregoryglass updated &#039;Xifaxan®(rifaximin) Tablets &#039;: Xifaxan®(rifaximin) Tablets
Company  SALIX
Date of First [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12321/</link>
				<pubDate>Mon, 31 Aug 2026 15:31:51 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>Xifaxan®(rifaximin) Tablets</b><br />
<b>Company </b> SALIX<br />
<b>Date of First Filing</b> December 18, 2015 and January 28, 2019 (200mg)</p>
<p><b>Paragraph IV Applicant:</b> Actavis<br />
<b>Case Name: </b> SALIX PHARMACEUTICALS LTD et al v. ACTAVIS LABORATORIES FL INC<br />
<b>Court/Case #: </b> Delaware District Court (dedc) 1:2016cv00188<br />
<b>Date Filed:</b> 3/23/16<br />
<b>Judge: </b> Sleet<br />
<b>Product Strength:</b> 550&hellip;<span class="activity-read-more" id="activity-read-more-12321"><a href="https://paragraphfour.com/activity/p/12321/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">962116d5dabcea8e1b62e0cba1bac808</guid>
				<title>gregoryglass updated &#039;OxyContin®(oxycodone) ER Tabs (NDA 22-272) Part 2 &#039;: OxyContin®(oxycodone) Extended-release Tablet (NDA 22-272) [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12304/</link>
				<pubDate>Sun, 30 Aug 2026 18:25:58 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>OxyContin®(oxycodone) Extended-release Tablet (NDA 22-272) Part 2</b><br />
<b>Company </b> PURDUE<br />
<b>Date of First Filing</b> October 4, 2010 (40mg), October 18, 2010 (30, 60, and 90mg), October 25, 2010 (10mg), October 28, 2010 (15mg), and October 29, 2010 (20mg).</p>
<p><b>Editor&#8217;s Note</b> This Product Topic covers the fifth set of cases filed on this product since 2001.&hellip;<span class="activity-read-more" id="activity-read-more-12304"><a href="https://paragraphfour.com/activity/p/12304/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">2dc837b7dda6c13dd4287dc15f5147f6</guid>
				<title>gregoryglass updated &#039;Myrbetriq®(mirabegron) Extended-release Tablets &#039;: Myrbetriq®(mirabegron) Extended-release Tablets
Annual [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12301/</link>
				<pubDate>Sun, 30 Aug 2026 17:22:48 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>Myrbetriq®(mirabegron) Extended-release Tablets</b><br />
<b>Annual Sales </b><br />
<b>Company </b> ASTELLAS<br />
<b>Date of First Filing</b> June 28, 2016</p>
<p><b>Special Summary Note #1:</b> In 2016, Astellas brought PIV actions against 9 ANDA filers as listed below. By October 2020, all of the parties settled these original cases. On 11/24/20, the USPTO issued a new patent (10,842,780,&hellip;<span class="activity-read-more" id="activity-read-more-12301"><a href="https://paragraphfour.com/activity/p/12301/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">57a8d651fdb55c806799161185bcb2a5</guid>
				<title>gregoryglass updated &#039;Jardiance®(empagliflozin) Tablets &#039;: Jardiance®(empagliflozin) Tablets
Annual Sales  $1.6B [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12296/</link>
				<pubDate>Sun, 30 Aug 2026 11:50:56 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>Jardiance®(empagliflozin) Tablets</b><br />
<b>Annual Sales </b> $1.6B (product family) (as reported by Eli Lilly)<br />
<b>Company </b> BOEHRINGER INGELHEIM<br />
<b>Date of First Filing</b> August 1, 2018</p>
<p><b>Special Note:</b> When these cases were filed, several of them also involve the combination product Glyxambi®(empagliflozin and linagliptin), Synjardy®(empagliflozin and me&hellip;<span class="activity-read-more" id="activity-read-more-12296"><a href="https://paragraphfour.com/activity/p/12296/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">dc723ea3526ad7838e45b78913cf6a8b</guid>
				<title>gregoryglass updated &#039;Jakafi®(ruxolitinib) Tablets &#039;: Jakafi®(ruxolitinib) Tablets 
Annual Sales  $2.79B
Company [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12295/</link>
				<pubDate>Sat, 29 Aug 2026 19:35:55 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>Jakafi®(ruxolitinib) Tablets </b><br />
<b>Annual Sales </b> $2.79B<br />
<b>Company </b> INCYTE<br />
<b>Date of First Filing</b> December 17, 2015</p>
<p><b>Special Note:</b> After this product received its first PIV Notice in 2015, Incyte did not file any PIV cases until 2024 when a case against Apotex. We had placed this product as a &#8220;No Litigation Pending&#8221; product, and we keep that entry&hellip;<span class="activity-read-more" id="activity-read-more-12295"><a href="https://paragraphfour.com/activity/p/12295/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">bdfd2488c79a5f0005fba2056ef0cce0</guid>
				<title>gregoryglass updated &#039;Inlyta®(axitinib) Tablets &#039;: Inlyta®(axitinib) Tablets
Company  PFIZER
Date of First [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12294/</link>
				<pubDate>Sat, 29 Aug 2026 19:31:10 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>Inlyta®(axitinib) Tablets</b><br />
<b>Company </b> PFIZER<br />
<b>Date of First Filing</b> February 23, 2018</p>
<p><b>Paragraph IV Applicant:</b> Apotex<br />
<b>Case Name: </b> PFIZER INC et al v. APOTEX INC et al<br />
<b>Court/Case #: </b> Delaware District Court (dedc) 1:2018cv00795<br />
<b>Date Filed:</b> 5/25/18<br />
<b>Judge: </b> Andrews<br />
<b>Product Strength:</b> 1 mg and 5 mg<br />
<b>Litigated Patents (expiration): </b> 8,791,140&hellip;<span class="activity-read-more" id="activity-read-more-12294"><a href="https://paragraphfour.com/activity/p/12294/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">939b89d5227fe8582ec5e6474c31eb20</guid>
				<title>gregoryglass updated &#039;Injectafer®(ferric carboxymaltose) Injection &#039;: Injectafer®(ferric carboxymaltose) Injection 
Company  VIFOR [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12293/</link>
				<pubDate>Sat, 29 Aug 2026 19:29:28 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>Injectafer®(ferric carboxymaltose) Injection </b><br />
<b>Company </b> VIFOR INTERNATIONAL<br />
<b>Date of First Filing</b> March 27, 2019 and February 22, 2024 (50 mg/10 mL)</p>
<p><b>Paragraph IV Applicant:</b> Mylan<br />
<b>Case Name: </b> VIFOR (INTERNATIONAL) AG et al v. MYLAN LABORATORIES LTD<br />
<b>Court/Case #: </b> New Jersey District Court (njdc) 3:2019cv13955<br />
<b>Date Filed:</b> 6/18/19<br />
<b>Judge: </b> Wolfs&hellip;<span class="activity-read-more" id="activity-read-more-12293"><a href="https://paragraphfour.com/activity/p/12293/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">61427793fa81e818ce4faaa01fa7e359</guid>
				<title>gregoryglass updated &#039;Hysingla ER®(hydrocodone) Extended Release Tablets &#039;: Hysingla ER®(hydrocodone) Extended Release Tablets
Company  [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12292/</link>
				<pubDate>Sat, 29 Aug 2026 19:22:32 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>Hysingla ER®(hydrocodone) Extended Release Tablets</b><br />
<b>Company </b> PURDUE<br />
<b>Date of First Filing</b> April 15, 2015 (20, 60, and 120mg) and May 8, 2015 (30, 40, 80, and 100mg)</p>
<p><b>Paragraph IV Applicant:</b> Actavis<br />
<b>Case Name: </b> PURDUE PHARMA LP et al v. ACTAVIS LABORATORIES FL INC<br />
<b>Court/Case #: </b> Delaware District Court (dedc) 1:2015cv00686<br />
<b>Date Filed:</b>&hellip;<span class="activity-read-more" id="activity-read-more-12292"><a href="https://paragraphfour.com/activity/p/12292/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">1083ac60a0143f0004a0c54bf9ed917e</guid>
				<title>gregoryglass updated &#039;Hetlioz®(tasimelteon) Capsules &#039;: Hetlioz®(tasimelteon) Capsules
Annual Sales  $76.7M [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12291/</link>
				<pubDate>Sat, 29 Aug 2026 19:18:33 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>Hetlioz®(tasimelteon) Capsules</b><br />
<b>Annual Sales </b> $76.7M (product family)<br />
<b>Company </b> VANDA PHARMACEUTICALS<br />
<b>Date of First Filing</b> January 31, 2018</p>
<p><b>Paragraph IV Applicant:</b> Teva<br />
<b>Case Name: </b> VANDA PHARMACEUTICALS INC v. TEVA PHARMACEUTICALS USA INC<br />
<b>Court/Case #: </b> Court of Appeals for the Federal Circuit (cafc) 23-1247<br />
<b>Date Filed:</b> 12/15/22<br />
<b>Judge: </b> Dyk&hellip;<span class="activity-read-more" id="activity-read-more-12291"><a href="https://paragraphfour.com/activity/p/12291/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">7170e429c8e0a39a31604919ec94d1f4</guid>
				<title>gregoryglass updated &#039;Bendeka®(bendamustine) Injection and Bendamustine &#039;: Bendeka®(bendamustine) Injection 
Bendamustine [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12279/</link>
				<pubDate>Sat, 29 Aug 2026 15:54:28 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>Bendeka®(bendamustine) Injection</b><br />
<b>Bendamustine Injection</b><br />
<b>Annual Sales </b> $168M<br />
<b>Company </b> CEPHALON<br />
<b>Date of First Filing</b> May 4, 2017 (Bendeka®(bendamustine) Injection) and July 17, 2018 (Bendeka Injection)</p>
<p><b>Special Note:</b> While it is our normal protocol to separate distinct NDA products, these products merit an exception. The B&hellip;<span class="activity-read-more" id="activity-read-more-12279"><a href="https://paragraphfour.com/activity/p/12279/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">97f86328327c4e7cc1ebbefad8b9e372</guid>
				<title>gregoryglass updated &#039;Belrapzo®(bendamustine) Injection &#039;: Belrapzo®(bendamustine) Injection
Company  EAGLE
Date of [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12278/</link>
				<pubDate>Sat, 29 Aug 2026 15:50:32 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>Belrapzo®(bendamustine) Injection</b><br />
<b>Company </b> EAGLE<br />
<b>Date of First Filing</b> Not applicable/reported by FDA</p>
<p><b>Paragraph IV Applicant:</b> Slayback<br />
<b>Case Name: </b> EAGLE PHARMACEUICALS INC v. SLAYBACK PHARMA LLC<br />
<b>Court/Case #: </b> Court of Appeals for the Federal Circuit (cafc) 19-1924<br />
<b>Date Filed:</b> 5/24/19<br />
<b>Judge: </b> O&#8217;Malley, Reyna, Chen<br />
<b>Product Strength:</b>&hellip;<span class="activity-read-more" id="activity-read-more-12278"><a href="https://paragraphfour.com/activity/p/12278/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">c740cc6601838e14ed59cc40dbfb17ca</guid>
				<title>gregoryglass updated &#039;Adempas®(riociguat) Tablets &#039;: Adempas®(riociguat) Tablets
Company  BAYER
Date of First [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12275/</link>
				<pubDate>Sat, 29 Aug 2026 15:35:01 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>Adempas®(riociguat) Tablets</b><br />
<b>Company </b> BAYER<br />
<b>Date of First Filing</b> October 10, 2017</p>
<p><b>Paragraph IV Applicant:</b> Alembic<br />
<b>Case Name: </b> ADVERIO PHARMA GMBH et al v. ALEMBIC PHARMACEUTICALS LTD et al<br />
<b>Court/Case #: </b> Delaware District Court (dedc) 1:2018cv00073<br />
<b>Date Filed:</b> 1/9/18<br />
<b>Judge: </b> Salas<br />
<b>Product Strength:</b> 0.5 mg, 1 mg, 1.5 mg, 2 mg and 2.5&hellip;<span class="activity-read-more" id="activity-read-more-12275"><a href="https://paragraphfour.com/activity/p/12275/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">edb50f72a6a1fbaee643f25b5cb3813c</guid>
				<title>gregoryglass updated &#039;Generic Companies Report #3 (Q-Z) &#039;: The Paragraph Four Report ®
Generic Companies Report #3 [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12274/</link>
				<pubDate>Thu, 27 Aug 2026 18:54:28 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>The Paragraph Four Report ®<br />
Generic Companies Report #3 (Q-Z)</b></p>
<p><b>List of Companies and Products under active Paragraph IV Certification</b><br />
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an &#8220;Old Case&#8221; (terminated after November 1,&hellip;<span class="activity-read-more" id="activity-read-more-12274"><a href="https://paragraphfour.com/activity/p/12274/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">f3c4b435449644b9c1f0474bc9350919</guid>
				<title>gregoryglass updated &#039;Adrenalin®(epinephrine) Injection &#039;: Adrenalin®(epinephrine) Injection
Company  PAR
Date of [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12273/</link>
				<pubDate>Thu, 27 Aug 2026 18:53:57 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>Adrenalin®(epinephrine) Injection</b><br />
<b>Company </b> PAR<br />
<b>Date of First Filing</b> March 9, 2016 and August 20, 2018 (30mg/30mL)</p>
<p><b>Paragraph IV Applicant:</b> Luitpold<br />
<b>Case Name: </b> PAR PHARMACEUTICAL INC et al v. LUITPOLD PHARMACEUTICALS INC et al<br />
<b>Court/Case #: </b> New Jersey District Court (nyedc) 2:2016cv02290<br />
<b>Date Filed:</b> 4/22/16<br />
<b>Judge: </b> Walls<br />
<b>Product&hellip;</b><span class="activity-read-more" id="activity-read-more-12273"><a href="https://paragraphfour.com/activity/p/12273/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">651339e1cedd88bd4c260af581a8b257</guid>
				<title>gregoryglass updated &#039;Generic Companies Report #2 (F-P) &#039;: The Paragraph Four Report ®
Generic Companies Report #2 [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12272/</link>
				<pubDate>Thu, 27 Aug 2026 18:39:05 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>The Paragraph Four Report ®<br />
Generic Companies Report #2 (F-P)</b></p>
<p><b>List of Companies and Products under active Paragraph IV Certification</b><br />
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an &#8220;Old Case&#8221; (terminated after November 1,&hellip;<span class="activity-read-more" id="activity-read-more-12272"><a href="https://paragraphfour.com/activity/p/12272/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">e4ba065b2feb5632088c54cd4a20171a</guid>
				<title>gregoryglass updated &#039;Jardiance®(empagliflozin) Tablets &#039;: Jardiance®(empagliflozin) Tablets
Annual Sales  $1.6B [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12271/</link>
				<pubDate>Thu, 27 Aug 2026 18:38:16 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>Jardiance®(empagliflozin) Tablets</b><br />
<b>Annual Sales </b> $1.6B (product family) (as reported by Eli Lilly)<br />
<b>Company </b> BOEHRINGER INGELHEIM<br />
<b>Date of First Filing</b> August 1, 2018</p>
<p><b>Special Note:</b> When these cases were filed, several of them also involve the combination product Glyxambi®(empagliflozin and linagliptin), Synjardy®(empagliflozin and me&hellip;<span class="activity-read-more" id="activity-read-more-12271"><a href="https://paragraphfour.com/activity/p/12271/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">f5916db3573a78e0c8b850d30551ccac</guid>
				<title>gregoryglass updated &#039;Nuedexta®(dextromethorphan and quinidine) Capsules &#039;: Nuedexta®(dextromethorphan and quinidine) Capsules
Company  [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12267/</link>
				<pubDate>Sun, 16 Aug 2026 19:43:11 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>Nuedexta®(dextromethorphan and quinidine) Capsules</b><br />
<b>Company </b> AVANIR<br />
<b>Date of First Filing</b> March 7, 2011</p>
<p><b>Paragraph IV Applicant:</b> Actavis<br />
<b>Case Name: </b> AVANIR PHARMACEUTICALS v. ACTAVIS SOUTH ATLANTIC LLC et al<br />
<b>Court/Case #: </b> Court of Appeals for the Federal Circuit (cafc) 14-1559 and 14-1838<br />
<b>Date Filed:</b> 6/10/14 and 9/11/14<br />
<b>Judge: </b> Bryson,&hellip;<span class="activity-read-more" id="activity-read-more-12267"><a href="https://paragraphfour.com/activity/p/12267/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">4f6a2b04da8575414bd1f2a4fa82bca8</guid>
				<title>gregoryglass updated &#039;Nuedexta®(dextromethorphan and quinidine) Capsules &#039;: Nuedexta®(dextromethorphan and quinidine) Capsules
Company  [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12266/</link>
				<pubDate>Sun, 16 Aug 2026 19:16:14 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>Nuedexta®(dextromethorphan and quinidine) Capsules</b><br />
<b>Company </b> AVANIR<br />
<b>Date of First Filing</b> March 7, 2011</p>
<p><b>Paragraph IV Applicant:</b> Actavis<br />
<b>Case Name: </b> AVANIR PHARMACEUTICALS v. ACTAVIS SOUTH ATLANTIC LLC et al<br />
<b>Court/Case #: </b> Court of Appeals for the Federal Circuit (cafc) 14-1559 and 14-1838<br />
<b>Date Filed:</b> 6/10/14 and 9/11/14<br />
<b>Judge: </b> Bryson,&hellip;<span class="activity-read-more" id="activity-read-more-12266"><a href="https://paragraphfour.com/activity/p/12266/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">6d3b28618cdb60780c7731e728814910</guid>
				<title>gregoryglass updated &#039;Nuedexta®(dextromethorphan and quinidine) Capsules &#039;: Nuedexta®(dextromethorphan and quinidine) Capsules
Company  [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12265/</link>
				<pubDate>Sat, 15 Aug 2026 15:02:32 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>Nuedexta®(dextromethorphan and quinidine) Capsules</b><br />
<b>Company </b> AVANIR<br />
<b>Date of First Filing</b> March 7, 2011</p>
<p><b>Paragraph IV Applicant:</b> Actavis<br />
<b>Case Name: </b> AVANIR PHARMACEUTICALS v. ACTAVIS SOUTH ATLANTIC LLC et al<br />
<b>Court/Case #: </b> Court of Appeals for the Federal Circuit (cafc) 14-1559 and 14-1838<br />
<b>Date Filed:</b> 6/10/14 and 9/11/14<br />
<b>Judge: </b> Bryson,&hellip;<span class="activity-read-more" id="activity-read-more-12265"><a href="https://paragraphfour.com/activity/p/12265/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">b922fcc8a53d8476e795d2c21e048ad9</guid>
				<title>gregoryglass updated &#039;Generic Companies Report #2 (F-P) &#039;: The Paragraph Four Report ®
Generic Companies Report #2 [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12262/</link>
				<pubDate>Tue, 11 Aug 2026 20:59:22 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>The Paragraph Four Report ®<br />
Generic Companies Report #2 (F-P)</b></p>
<p><b>List of Companies and Products under active Paragraph IV Certification</b><br />
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an &#8220;Old Case&#8221; (terminated after November 1,&hellip;<span class="activity-read-more" id="activity-read-more-12262"><a href="https://paragraphfour.com/activity/p/12262/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">18bb2a7adbc1bfb1522a31791972b33c</guid>
				<title>gregoryglass updated &#039;Generic Companies Report #3 (Q-Z) &#039;: The Paragraph Four Report ®
Generic Companies Report #3 [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12258/</link>
				<pubDate>Mon, 10 Aug 2026 20:45:15 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>The Paragraph Four Report ®<br />
Generic Companies Report #3 (Q-Z)</b></p>
<p><b>List of Companies and Products under active Paragraph IV Certification</b><br />
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an &#8220;Old Case&#8221; (terminated after November 1,&hellip;<span class="activity-read-more" id="activity-read-more-12258"><a href="https://paragraphfour.com/activity/p/12258/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">5765404ada95c6224610c0f83e9ddc08</guid>
				<title>gregoryglass updated &#039;Generic Companies Report #3 (Q-Z) &#039;: The Paragraph Four Report ®
Generic Companies Report #3 [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12255/</link>
				<pubDate>Fri, 07 Aug 2026 23:22:52 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>The Paragraph Four Report ®<br />
Generic Companies Report #3 (Q-Z)</b></p>
<p><b>List of Companies and Products under active Paragraph IV Certification</b><br />
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an &#8220;Old Case&#8221; (terminated after November 1,&hellip;<span class="activity-read-more" id="activity-read-more-12255"><a href="https://paragraphfour.com/activity/p/12255/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">ade7dd2875c336fb75e7b18e7587b3ca</guid>
				<title>gregoryglass updated &#039;Generic Companies Report #2 (F-P) &#039;: The Paragraph Four Report ®
Generic Companies Report #2 [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12254/</link>
				<pubDate>Fri, 07 Aug 2026 23:21:29 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>The Paragraph Four Report ®<br />
Generic Companies Report #2 (F-P)</b></p>
<p><b>List of Companies and Products under active Paragraph IV Certification</b><br />
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an &#8220;Old Case&#8221; (terminated after November 1,&hellip;<span class="activity-read-more" id="activity-read-more-12254"><a href="https://paragraphfour.com/activity/p/12254/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">e3285d83f95a03d907131cdaf12601c4</guid>
				<title>gregoryglass updated &#039;Generic Companies Report #1 (A-E) &#039;: The Paragraph Four Report ®
Generic Companies Report #1 [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12253/</link>
				<pubDate>Fri, 07 Aug 2026 23:19:30 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>The Paragraph Four Report ®<br />
Generic Companies Report #1 (A-E)</b></p>
<p><b>List of Companies and Products under active Paragraph IV Certification</b><br />
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an &#8220;Old Case&#8221; (terminated after November 1,&hellip;<span class="activity-read-more" id="activity-read-more-12253"><a href="https://paragraphfour.com/activity/p/12253/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">725f88f364afaebbd0e73cbe6cd5c783</guid>
				<title>gregoryglass updated &#039;Branded Companies Report &#039;: The Paragraph Four Report ®
Branded Companies [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12252/</link>
				<pubDate>Fri, 07 Aug 2026 23:17:16 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>The Paragraph Four Report ®<br />
Branded Companies Report</b></p>
<p><b>List of Companies with Products under active Paragraph IV Certification</b><br />
Data includes total number and product and includes products that do not have a lawsuit filed (when verified by other sources). An Asterisk (*) indicates an &#8220;Old Case&#8221; (terminated after November 1, 2003)</p>
<p><b>ABBVIE&hellip;</b><span class="activity-read-more" id="activity-read-more-12252"><a href="https://paragraphfour.com/activity/p/12252/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">9674e04b9d67428ee064482c09b5ee24</guid>
				<title>gregoryglass updated &#039;Paragraph IV Appellate Judges (Linn &#8211; Newman) &#039;: The Paragraph Four Report®
The Appellate Judges (Linn - [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12247/</link>
				<pubDate>Wed, 05 Aug 2026 13:57:10 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>The Paragraph Four Report®</b><br />
<b>The Appellate Judges (Linn &#8211; Newman)</b></p>
<p>This Section provides data on federal judges who preside in The Federal Circuit Court of Appeals. The Federal Circuit has exclusive appellate jurisdiction over Paragraph IV cases which means that a party that loses in the district court can only appeal the decision to the Federal&hellip;<span class="activity-read-more" id="activity-read-more-12247"><a href="https://paragraphfour.com/activity/p/12247/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">e50d51b2f85e5dbb7195374d9c8269ac</guid>
				<title>gregoryglass updated &#039;Paragraph IV Appellate Judges (Bryson-Hughes) &#039;: The Paragraph Four Report®
The Appellate Judges (Bryson - [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12246/</link>
				<pubDate>Wed, 05 Aug 2026 13:56:12 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>The Paragraph Four Report®</b><br />
<b>The Appellate Judges (Bryson &#8211; Hughes)</b></p>
<p>This Section provides data on federal judges who preside in The Federal Circuit Court of Appeals. The Federal Circuit has exclusive appellate jurisdiction over Paragraph IV cases which means that a party that loses in the district court can only appeal the decision to the&hellip;<span class="activity-read-more" id="activity-read-more-12246"><a href="https://paragraphfour.com/activity/p/12246/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">3706868679411acf928a949b2d322d8f</guid>
				<title>gregoryglass updated &#039;Paragraph IV Appellate Judges (Prost &#8211; Reyna) &#039;: The Paragraph Four Report®
The Appellate Judges (Prost - [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12245/</link>
				<pubDate>Wed, 05 Aug 2026 13:55:27 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>The Paragraph Four Report®</b><br />
<b>The Appellate Judges (Prost &#8211; Reyna)</b></p>
<p>This Section provides data on federal judges who preside in The Federal Circuit Court of Appeals. The Federal Circuit has exclusive appellate jurisdiction over Paragraph IV cases which means that a party that loses in the district court can only appeal the decision to the Federal&hellip;<span class="activity-read-more" id="activity-read-more-12245"><a href="https://paragraphfour.com/activity/p/12245/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">9b87a530d6a3d14d1fc1b7bd009389e6</guid>
				<title>gregoryglass updated &#039;Court of Appeals Decisions &#8211; by Case Name &#039;: The Paragraph Four Report®
Court of Appeals Opinions by [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12244/</link>
				<pubDate>Wed, 05 Aug 2026 13:53:33 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>The Paragraph Four Report®</b><br />
<b>Court of Appeals Opinions by Case Name</b></p>
<p>Opinions from the Court of Appeals for the Federal Circuit can be found in several places in ParagraphFour.com. Each Opinion issued for a particular product can be found under the product name, and you can also see how each individual Appellate Judge ruled in their various&hellip;<span class="activity-read-more" id="activity-read-more-12244"><a href="https://paragraphfour.com/activity/p/12244/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">6d3edac021ff1e40613792692b702264</guid>
				<title>gregoryglass updated &#039;Last Month&#8217;s Paragraph IV Highlights &#039;: July 2026</title>
				<link>https://paragraphfour.com/activity/p/12241/</link>
				<pubDate>Sat, 01 Aug 2026 15:47:24 -0400</pubDate>

									<content:encoded><![CDATA[<p>July 2026</p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">792c9c3d1fe24db4694a88d8a2dcef71</guid>
				<title>gregoryglass updated &#039;Generic Companies Report #3 (Q-Z) &#039;: The Paragraph Four Report ®
Generic Companies Report #3 [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12239/</link>
				<pubDate>Sat, 01 Aug 2026 15:10:04 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>The Paragraph Four Report ®<br />
Generic Companies Report #3 (Q-Z)</b></p>
<p><b>List of Companies and Products under active Paragraph IV Certification</b><br />
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an &#8220;Old Case&#8221; (terminated after November 1,&hellip;<span class="activity-read-more" id="activity-read-more-12239"><a href="https://paragraphfour.com/activity/p/12239/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">41815340d9de92c481b42ca10fa58215</guid>
				<title>gregoryglass updated &#039;Representation List (Branded) &#039;: The Paragraph Four Report®
Representation List (Branded [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12237/</link>
				<pubDate>Sat, 01 Aug 2026 14:33:52 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>The Paragraph Four Report®</b><br />
<b>Representation List (Branded Companies)</b></p>
<p>In March 2019, we reconstructed this section. The original section covered all law firms representing brand companies in PIV cases filed since 2003. The original list of branded companies with represented law firms is in this pdf file, if you need it for reference:<br />
<a href="https://paragraphfour.com/uploads/educ/Representation List Brand Legacy.pdf" rel="nofollow ugc"><img loading="lazy" src="https://paragraphfour.com/html/mime_types/pdf.gif" /> Legacy&hellip;</a><span class="activity-read-more" id="activity-read-more-12237"><a href="https://paragraphfour.com/activity/p/12237/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">142d7bdea0992bfe2f41456a77b5ceda</guid>
				<title>gregoryglass updated &#039;Generic Companies Report #2 (F-P) &#039;: The Paragraph Four Report ®
Generic Companies Report #2 [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12236/</link>
				<pubDate>Sat, 01 Aug 2026 14:30:43 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>The Paragraph Four Report ®<br />
Generic Companies Report #2 (F-P)</b></p>
<p><b>List of Companies and Products under active Paragraph IV Certification</b><br />
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an &#8220;Old Case&#8221; (terminated after November 1,&hellip;<span class="activity-read-more" id="activity-read-more-12236"><a href="https://paragraphfour.com/activity/p/12236/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d0637ca5c81c75159403972001bd627d</guid>
				<title>gregoryglass updated &#039;Branded Companies Report &#039;: The Paragraph Four Report ®
Branded Companies [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12235/</link>
				<pubDate>Sat, 01 Aug 2026 14:29:54 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>The Paragraph Four Report ®<br />
Branded Companies Report</b></p>
<p><b>List of Companies with Products under active Paragraph IV Certification</b><br />
Data includes total number and product and includes products that do not have a lawsuit filed (when verified by other sources). An Asterisk (*) indicates an &#8220;Old Case&#8221; (terminated after November 1, 2003)</p>
<p><b>ABBVIE&hellip;</b><span class="activity-read-more" id="activity-read-more-12235"><a href="https://paragraphfour.com/activity/p/12235/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">dbc59ea455c55cedc7cf968097c9bbbe</guid>
				<title>gregoryglass updated &#039;Generic Companies Report #2 (F-P) &#039;: The Paragraph Four Report ®
Generic Companies Report #2 [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12232/</link>
				<pubDate>Sat, 01 Aug 2026 11:09:57 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>The Paragraph Four Report ®<br />
Generic Companies Report #2 (F-P)</b></p>
<p><b>List of Companies and Products under active Paragraph IV Certification</b><br />
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an &#8220;Old Case&#8221; (terminated after November 1,&hellip;<span class="activity-read-more" id="activity-read-more-12232"><a href="https://paragraphfour.com/activity/p/12232/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">ff108cc2c4800219b7ca6dce00f38201</guid>
				<title>gregoryglass updated &#039;Generic Companies Report #1 (A-E) &#039;: The Paragraph Four Report ®
Generic Companies Report #1 [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12230/</link>
				<pubDate>Fri, 31 Jul 2026 21:18:33 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>The Paragraph Four Report ®<br />
Generic Companies Report #1 (A-E)</b></p>
<p><b>List of Companies and Products under active Paragraph IV Certification</b><br />
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an &#8220;Old Case&#8221; (terminated after November 1,&hellip;<span class="activity-read-more" id="activity-read-more-12230"><a href="https://paragraphfour.com/activity/p/12230/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">4d0c908b62aec5bf233d1ea59d2d1727</guid>
				<title>gregoryglass updated &#039;Generic Companies Report #1 (A-E) &#039;: The Paragraph Four Report ®
Generic Companies Report #1 [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12228/</link>
				<pubDate>Fri, 31 Jul 2026 20:54:16 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>The Paragraph Four Report ®<br />
Generic Companies Report #1 (A-E)</b></p>
<p><b>List of Companies and Products under active Paragraph IV Certification</b><br />
Data includes total number and product and includes products that do not have a lawsuit filed (only when verified by other sources). An Asterisk (*) indicates an &#8220;Old Case&#8221; (terminated after November 1,&hellip;<span class="activity-read-more" id="activity-read-more-12228"><a href="https://paragraphfour.com/activity/p/12228/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">6e28658dbf09e2ef62495146934ab545</guid>
				<title>gregoryglass updated &#039;Fanapt®(iloperidone) Tablets &#039;: Fanapt®(iloperidone) Tablets
Company  NOVARTIS 
Date of [&#133;]</title>
				<link>https://paragraphfour.com/activity/p/12227/</link>
				<pubDate>Fri, 31 Jul 2026 20:53:47 -0400</pubDate>

									<content:encoded><![CDATA[<p><b>Fanapt®(iloperidone) Tablets</b><br />
<b>Company </b> NOVARTIS<br />
<b>Date of First Filing</b> May 5, 2013</p>
<p><b>Paragraph IV Applicant:</b> Roxane<br />
<b>Case Name: </b> NOVARTIS PHARMACEUTICALS CORP et al v. ROXANE LABORATORIES INC<br />
<b>Court/Case #: </b> Court of Appeals for the Federal Circuit (cafc) 16-2707<br />
<b>Date Filed:</b> 9/26/16<br />
<b>Judge: </b> Lourie, Prost, Hughes<br />
<b>Product Strength:</b> 1, 2, 4, 6,&hellip;<span class="activity-read-more" id="activity-read-more-12227"><a href="https://paragraphfour.com/activity/p/12227/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>